1. Home
  2. EQPT vs BLTE Comparison

EQPT vs BLTE Comparison

Compare EQPT & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EQPT

EquipmentShare.com Inc Common Stock

N/A

Current Price

$19.97

Market Cap

5.8B

Sector

N/A

ML Signal

N/A

Logo Belite Bio Inc

BLTE

Belite Bio Inc

N/A

Current Price

$139.63

Market Cap

6.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EQPT
BLTE
Founded
2015
2018
Country
United States
United States
Employees
8206
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.2B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EQPT
BLTE
Price
$19.97
$139.63
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$38.88
$198.00
AVG Volume (30 Days)
2.4M
204.1K
Earning Date
03-18-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$21.53
N/A
Revenue Next Year
$23.15
$492.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.95
$56.68
52 Week High
$35.50
$200.00

Technical Indicators

Market Signals
Indicator
EQPT
BLTE
Relative Strength Index (RSI) 46.34 42.21
Support Level $18.94 $103.94
Resistance Level $26.57 $157.99
Average True Range (ATR) 1.48 9.31
MACD -0.19 0.39
Stochastic Oscillator 31.46 41.30

Price Performance

Historical Comparison
EQPT
BLTE

About EQPT EquipmentShare.com Inc Common Stock

EquipmentShare.com Inc is a vertically integrated platform that combines proprietary technology, a connected equipment fleet, and a nationwide footprint to serve the construction industry. The company operates its business through the following reportable segments: Equipment Rental and Services Operations, comprised of recurring activity performed at full-service branch locations, such as equipment rentals and related services, and sales of parts, supplies, and maintenance services to construction contractors and others. Equipment Sales, sales of new or used equipment made at any of the branch locations and dealership sites, including equipment sales to participants in the OWN Program.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Share on Social Networks: